Quidel Co. (QDEL) Shares Sold by Gamco Investors INC. ET AL
Gamco Investors INC. ET AL lowered its holdings in shares of Quidel Co. (NASDAQ:QDEL) by 0.4% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 505,700 shares of the company’s stock after selling 2,000 shares during the period. Gamco Investors INC. ET AL owned 1.29% of Quidel worth $24,688,000 as of its most recent filing with the SEC.
A number of other institutional investors have also bought and sold shares of the stock. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Quidel by 16.5% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,353 shares of the company’s stock worth $115,000 after acquiring an additional 333 shares during the period. Meeder Asset Management Inc. boosted its holdings in shares of Quidel by 383.5% during the third quarter. Meeder Asset Management Inc. now owns 2,659 shares of the company’s stock worth $173,000 after acquiring an additional 2,109 shares during the period. Quantamental Technologies LLC bought a new stake in shares of Quidel during the fourth quarter worth approximately $149,000. Alambic Investment Management L.P. bought a new stake in shares of Quidel during the third quarter worth approximately $205,000. Finally, Stevens Capital Management LP bought a new stake in shares of Quidel during the third quarter worth approximately $224,000. Institutional investors and hedge funds own 90.32% of the company’s stock.
In other news, CFO Randall J. Steward sold 15,000 shares of Quidel stock in a transaction that occurred on Monday, December 3rd. The shares were sold at an average price of $61.51, for a total value of $922,650.00. Following the completion of the sale, the chief financial officer now directly owns 16,790 shares in the company, valued at $1,032,752.90. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Douglas C. Bryant sold 25,250 shares of Quidel stock in a transaction that occurred on Tuesday, January 29th. The shares were sold at an average price of $55.09, for a total transaction of $1,391,022.50. Following the completion of the sale, the chief executive officer now owns 319,563 shares of the company’s stock, valued at $17,604,725.67. The disclosure for this sale can be found here. Over the last quarter, insiders sold 58,283 shares of company stock valued at $3,416,751. 16.70% of the stock is owned by company insiders.
NASDAQ QDEL opened at $57.87 on Friday. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.26 and a quick ratio of 0.86. Quidel Co. has a 1-year low of $41.50 and a 1-year high of $77.63. The company has a market capitalization of $2.28 billion, a PE ratio of -826.71, a price-to-earnings-growth ratio of 0.87 and a beta of 1.27.
Quidel (NASDAQ:QDEL) last released its quarterly earnings results on Tuesday, November 6th. The company reported $0.59 earnings per share for the quarter, beating analysts’ consensus estimates of $0.43 by $0.16. Quidel had a net margin of 7.26% and a return on equity of 25.63%. The company had revenue of $117.40 million during the quarter, compared to the consensus estimate of $120.09 million. During the same period in the previous year, the business earned $0.17 earnings per share. The firm’s quarterly revenue was up 130.6% on a year-over-year basis. On average, sell-side analysts anticipate that Quidel Co. will post 2.61 earnings per share for the current year.
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology. The company offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus products point-of-care products for the detection of infectious and inflammatory diseases and conditions of the eye.
See Also: What is a stock buyback?
Receive News & Ratings for Quidel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quidel and related companies with MarketBeat.com's FREE daily email newsletter.